Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis-Reference-Cited by-同舟云学术

Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis

Published:2018-12-19 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Jabbar Basit,Rafique Shazia,Salo-Ahen Outi M. H.,Ali Amjad,Munir Mobeen,Idrees Muhammad,Mirza Muhammad Usman,Vanmeert Michiel,Shah Syed Zawar,Jabbar Iqra,Rana Muhammad Adeel

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference80 articles.

1. Current status of human papillomavirus vaccines;Kim;Clin Exp Vaccine Res.,2014

2. Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines;Jagu;JNCI,2009

3. A review of human carcinogens–Part B: biological agents;Bouvard;Lancet Oncology,2009

4. Current status and future prospects for human papillomavirus vaccines;Kim;Arch Pharm Res.,2017

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease;Viruses;2024-08-03

2. Specific targeting of cancer vaccines to antigen-presenting cells via an endogenous TLR2/6 ligand derived from cysteinyl-tRNA synthetase 1;Molecular Therapy;2024-07

3. Development of membrane protein‐based vaccine against lumpy skin disease virus (LSDV) using immunoinformatic tools;Veterinary Medicine and Science;2024-03-31

4. Structural and Dynamic-Based Characterization of the Recognition Patterns of E7 and TRP-2 Epitopes by MHC Class I Receptors through Computational Approaches;International Journal of Molecular Sciences;2024-01-23

5. Immunodominant conserved moieties on spike protein of SARS-CoV-2 renders virulence factor for the design of epitope-based peptide vaccines;VirusDisease;2023-11-23